MedTrace Logo

Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities

NCT05711108 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2025-10-22

No results posted yet for this study

Summary

To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing facility (SNF) or nursing home (NH), on different hypoglycemic medications).

This aim will be achieved by recruiting 300 residents with diabetes in 4 LTC facilities. All participants will undergo masked CGM for 10 days.

Conditions

Sponsors & Collaborators

  • Theoria Medical

    collaborator UNKNOWN

  • Joslin Diabetes Center

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-19
Primary Completion
2024-11-30
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05711108 on ClinicalTrials.gov